Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 484
Selected: 0
NCT IDTitle
NCT06255197Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers
NCT05603078A Prospective Study of Preoperative Tumor-bed Boost Followed by Oncoplastic Surgery and Adjuvant Whole Breast Radiotherapy for Early Stage Breast Cancer (BIRKIN)
NCT03714490MRI Simulation-guided Boost in Short-course Preoperative Radiotherapy for Unresectable Rectal Cancer
NCT03772496Diagnostic Significance of CTCs in Patients With Thyroid Nodules (Circulating Tumor Cells)
NCT04079283Radiomics of Immunotherapeutics Response Evaluation and Prediction
NCT06848842Ivonescimab Plus Chemotherapy in Patients With Initially Unresectable Colorectal Cancer Liver Metastases
NCT06544668A Study for Dynamic Prediction Model of Breast Cancer Bone Metastases
NCT03420079A Phase I Study of FCN-411 in Advanced Non-small Cell Lung Cancer Chinese Patients With EGFR Positive Mutation
NCT07063888A Prospective Phase II Study of Postoperative Concurrent Chemoradiotherapy in Patients With Intrahepatic Cholangiocarcinoma
NCT02979691Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esophagogastric Cancer - 3JECROG P-01
NCT05349968Pharmacokinetics and Efficacy of Multiple Dosing of Lipovirtide for Injection in HIV-infected Patients
NCT07141771An Umbrella Study of Recurrent, Extensive Stage Small Cell Lung Cancer Based on Molecular Typing
NCT07019337Oral Metronomic Capecitabine Combined With Pyrotinib in ADC-treated HER2-positive Metastatic Breast Cancer
NCT06149533Evaluate the Efficacy and Safety of Edoxaban on Prevention of Catheter-related Thrombosis (CRT) in Cancer Patients
NCT05749016Neoadjuvant Inetetamab Combined With Pertuzumab and Paclitaxel/Carboplatin for Breast Cancer
NCT02143388Concurrent Cisplatin Chemoradiation With or Without Capecitabine as Adjuvant Chemotherapy in Local Advanced High Risk Nasopharyngeal Carcinoma: Randomized Control Clinical Trial
NCT03844360Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease
NCT06897046Perioperative Study of Iparomlimab and Tuvonralimab in Resectable NSCLC
NCT02500810Monosialoganglioside Preventing Neurotoxicity Induced by Albumin-bound Paclitaxel Chemotherapy in Lung Cancer Patients
NCT06773507Phase I Study of BC008-1A Injection in Patients With Advanced Solid Tumors
NCT02635503Safety Study of Totally Laparoscopic Resection With Natural Orifice Specimen Extraction (NOSE) for Rectosigmoid Cancer
NCT07057102Multiple Omics Sequencing Technologies in Predicting the Efficacy and Monitoring the Recurrence of Non-Small Cell Lung Cancer
NCT06540937Phase II Clinical Study of Leflunomide in the Treatment of MEN-1 Neuroendocrine Tumor
NCT06667622Sodium Glycididazole Reduces the Adverse Reactions of Concurrent Chemoradiotherapy
NCT05541445Pembrolizumab Plus CRT Followed by Surgery in Upper ESCC
NCT05028439RFA Combined With Chemotherapy for Unresectable Cholangiocarcinoma
NCT05411705Efficacy and Safety of rhTPO's Prophylactic Treatment of CTIT in Patients With High Risk of Cardiac Injury
NCT04339660Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 Pneumonia
NCT03298204Definitive (Chemo)Radiotherapy for Patients With Esophageal Cancer - 3JECROG R-01
NCT07317778Chemotherapy With or Without Adebrelimab and T-DXh as Neoadjuvant Therapy for HR+/HER2 Low Early Stage Breast Cancer
NCT06354036Transhiatal Tunnel Valvuloplasty for Reconstruction Following the Laparoscopic Proximal Gastrectomy
NCT06229067Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With Metronomic VEX in Advanced Triple-negative Breast Cancer
NCT02053948Pursestring Wound Closure vs "Gunsight" Skin Incision and Closure Technique to Reverse Stoma
NCT06540508Application of Integrated Proteomic and Serum Metabolomic Analysis in Assessing the Efficacy and Prognosis of TACE Combined With Targeted Immunotherapy in Unresectable Hepatocellular Carcinoma
NCT07107815A Study On The Prediction of Neoadjuvant Efficacy For Rectal Cancer Based On MR Cytometry Imaging and Deep-radiomics
NCT06857747Disitamab Vedotin in Combination with Metronomic Chemotherapy in Advanced HER2-expressing Breast Cancer.
NCT06761846Sintilimab Combined With Chemotherapy as Adjuvant Treatment for Phase III GC and GEJ
NCT06416930Study of Cadonilimab Combined With Chemotherapy in Recurrent / Refractory Pleural Mesothelioma
NCT07239271A Multicenter Phase III Clinical Study and Translational Research on Adaptive Neoadjuvant Therapy of De-escalation and Escalation for HER2-Positive Breast Cancer Based on Multi-Omics Response Evaluation Model
NCT03583580Accelerated Partial Breast Irradiation With IMRT in Early Breast Cancer
NCT04807673Pembrolizumab Plus Neoadjuvant Chemotherapy vs. Neoadjuvant Chemoradiotherapy for Locally Advanced ESCC (KEYSTONE-002)
NCT06857305Efficacy and Safety of Biweekly Regimen of Eribulin Versus a Standard Regimen for the Treatment of Locally Recurrent or Metastatic HER2-negative Breast Cancer: a Multicenter, Randomized, Open-label, Phase III Trial
NCT02861196Research on the Combined-Modality Treatment Model of Bladder Preservation in Muscular Invasive Bladder Cancer
NCT03383562Daytime Variation of Complication in Gastric and Pancreatic Surgery
NCT05894889Pembrolizumab and Chemotherapy Neoadjuvant/Adjuvant of NSCLC
NCT05749289Application of Al18F-octreotide PET/CT in Neuroendocrine Tumor
NCT05888402Induction Chemotherapy and Toripalimab Followed by Chemoradiotherapy for Large-volume Local Advanced NSCLC
NCT03781050Efficacy of Rapamycin (Sirolimus) in the Treatment of Peutz-Jeghers Syndrome
NCT04821843Neoadjuvant Treatment Modalities in Esophageal Cancer
NCT05986227The Sequential Combination of FOLFOX and Toripalimab for Perioperative Immuno-Oncology Therapy of HER2-negative Adenocarcinoma of the Esophagogastric Junction (Siewert I/II):